Prevention and control of influenza recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for Disease Control and Prevention.
These recommendations update information on the vaccine and antiviral agents available for controlling influenza during the 1995-96 influenza season (superseding MMWR 1994;43(No. RR-9) 1-13 and MMWR 1994;43(No. RR-15): 1-10). The principal changes include information about a) the influenza virus strains included in the trivalent vaccine for 1995-96, b) side effects and adverse reactions, and c) the vaccination of pregnant women.
D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D006801:Humans; D007115:Immunization Schedule; D009980:Influenza A virus / Q000276:immunology; D009981:Influenza B virus / Q000276:immunology; D007252:Influenza Vaccines / Q000008:administration & dosage* / Q000009:adverse effects / Q000276:immunology; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control*; D012299:Rimantadine / Q000627:therapeutic use; D015164:Vaccines, Inactivated
D000998:Antiviral Agents; D007252:Influenza Vaccines; D015164:Vaccines, Inactivated; D012299:Rimantadine; D000547:Amantadine